InvestorsHub Logo
Followers 43
Posts 7395
Boards Moderated 0
Alias Born 07/09/2010

Re: Inorout post# 119970

Thursday, 09/22/2016 2:44:16 PM

Thursday, September 22, 2016 2:44:16 PM

Post# of 129051
Dabney has 22 convictions for stock fraud and has been sentenced for selling unregistered shares.. Canno wait to see how many millions be made off false and misleading news trading I. The bogat family trust...Feds are about to chew this lying fucking asshole up
IRVINE, CA--(Marketwired - Sep 6, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is excited to announce they have received their initial batch of nebulizers for their cannabinoid-based MDI rescue inhalers, which targets asthma/COPD for legal self-medicating patients. Previous third-party studies using cannabis-based treatments for asthma/COPD have shown positive results with fewer side effects, and that has spurred the company to move to market as quickly as possible to capitalize on the infancy of the market.
In addition to select dispensaries in California, the company will be testing the initial batch out with 20-25 legal self-medicating candidates suffering from asthma/COPD and other respiratory ailments in the State of California. The observational study will allow the company to confirm observation efficacy, develop additional marketing materials, and improve product design while building a wider spread release.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.